Cardiology
RSSArticles
Full February 15, 2004, Issue in PDF
Clinical Briefs
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera; Coronary Artery Calcium Score Plus Framingham Score for Risk Prediction; Intra-Articular Hyaluronic Acid in the Treatment of Knee OsteoarthritisPharmacology Update: Olanzapine and Fluoxetine Capsules (Symbyax — Lilly)
The FDA has approved a combination of olanzapine and fluoxetine for the treatment of depressive episodes associated with bipolar disorder.Another Tool for a Common Problem
Intranasal fluticasone helps sleep-disordered breathing in patients with allergic rhinitis.Clinical Briefs in Primary Care Supplement
Exercise Training for Angina
A 12-month program of regular exercise in selected patients with chronic stable angina and significant CAD resulted in a higher event-free survival and exercise capacity at lower costs than PCI.More Late-Breaking Clinical Trials Presented at the American College of Cardiology Meeting
Drs. Stuart Connolly and Stefan Hohnloser presented results from the Defibrillator In Acute Myocardial Infarction Trial (DINAMIT). Prior studies had shown that patients with recent myocardial infarction and left ventricular dysfunction are at high risk for death in the period after myocardial infarction.Full March issue in PDF
Pharmacology Watch: Sinus and Allergy Health Partnership Releases New Guidelines for Treatment of Bacterial Rhinosinusitis
Steroids Not Linked to Risk of Fractures; ADT Puts Men at Risk for Osteoporosis; Study Shows Valsartan May Improve Sexual Function in Postmenopausal Women; New Direct-to-Consumer Pharma Advertising Rules Considered; FDA ActionsRecruitment Maneuvers Still Controversial in ALI/ARDS
In patients with ALI/ARDS from pulmonary and extrapulmonary causes, receiving mechanical ventilation with low tidal volumes and high PEEP, short-term effects of recruitment maneuvers as conducted in this study are variable.